Akero Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 67

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 11

Akero Therapeutics General Information

Description

Developer of biopharmaceuticals designed to treat serious metabolic diseases. The company's technology utilizes an engineered analog of fibroblast growth factor 21 to regulate lipid and carbohydrate metabolism, enabling patients with metabolic dysfunction-associated steatohepatitis to restore whole-body metabolic balance and reverse liver fibrosis.

Contact Information

Website
www.akerotx.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 601 Gateway Boulevard
  • Suite 350
  • South San Francisco, CA 94080
  • United States
+1 (650)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Parent Company
Novo Nordisk
Vertical(s)
Former Stock Listing
AKRO
Corporate Office
  • 601 Gateway Boulevard
  • Suite 350
  • South San Francisco, CA 94080
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Akero Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Akero Therapeutics‘s full profile, request access.

Request a free trial

Akero Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceuticals designed to treat serious metabolic diseases. The company's technology utilizes an engin
Drug Discovery
South San Francisco, CA
67 As of 2025

South San Francisco, CA
 

Plymouth Meeting, PA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Akero Therapeutics Competitors (71)

One of Akero Therapeutics’s 71 competitors is NGM Biopharmaceuticals, a Private Equity-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NGM Biopharmaceuticals Private Equity-Backed South San Francisco, CA
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Blade Therapeutics Venture Capital-Backed San Francisco, CA
Altimmune Formerly VC-backed Gaithersburg, MD
Galectin Therapeutics Corporation Norcross, GA
You’re viewing 5 of 71 competitors. Get the full list »

Akero Therapeutics Patents

Akero Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025155843-A1 Method of treating liver or lung injury Pending 19-Jan-2024
WO-2025123025-A1 Plunger rod assembly configured to reduce use error associated with operation of a medical device including the plunger rod assembly Inactive 08-Dec-2023
AU-2023343076-A1 Fgf21 mutant polypeptides Pending 12-Sep-2022
EP-4587458-A1 Fgf21 mutant polypeptides Pending 12-Sep-2022
WO-2024059507-A1 Fgf21 mutant polypeptides Inactive 12-Sep-2022 C07K14/50
To view Akero Therapeutics’s complete patent history, request access »

Akero Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akero Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Akero Therapeutics‘s full profile, request access.

Request a free trial

Akero Therapeutics FAQs

  • When was Akero Therapeutics founded?

    Akero Therapeutics was founded in 2017.

  • Where is Akero Therapeutics headquartered?

    Akero Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Akero Therapeutics?

    Akero Therapeutics has 67 total employees.

  • What industry is Akero Therapeutics in?

    Akero Therapeutics’s primary industry is Drug Discovery.

  • Is Akero Therapeutics a private or public company?

    Akero Therapeutics is a Private company.

  • What is the current valuation of Akero Therapeutics?

    The current valuation of Akero Therapeutics is .

  • What is Akero Therapeutics’s current revenue?

    The current revenue for Akero Therapeutics is .

  • How much funding has Akero Therapeutics raised over time?

    Akero Therapeutics has raised $1.49B.

  • Who are Akero Therapeutics’s investors?

    Adage Capital Management, Amgen, Apple Tree Partners (ATP), Atlas Venture, and Avidity Partners are 5 of 23 investors who have invested in Akero Therapeutics.

  • Who are Akero Therapeutics’s competitors?

    NGM Biopharmaceuticals, Inovio Pharmaceuticals, Blade Therapeutics, Altimmune, and Galectin Therapeutics are some of the 71 competitors of Akero Therapeutics.

  • When was Akero Therapeutics acquired?

    Akero Therapeutics was acquired on 09-Oct-2025.

  • Who acquired Akero Therapeutics?

    Akero Therapeutics was acquired by Novo Nordisk.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process